← Leaderboards
Lauren Elizabeth Ball
Medical University Of South Carolina
$10,053,302
Attributed
$11,548,055
Total exposure
12
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.9M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$11,548,055 · 12
By mechanism
S10$4,022,240 · 4
U01$2,989,507 · 1
R01$1,807,024 · 1
P20$1,371,109 · 4
P30$1,358,175 · 2
Top collaborators
- Mauricio J. Reginato8 shared
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Philip H Howe$17,002,249
- Jessica Marie Trombetta-Esilva$183,363
- Ken Noguchi$160,900
- Emilie Moore Rosset$150,984
- Jessica Helene Hartman$3,284,960
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsSignal TransductionEnzymesCellsGrantGlycosylationPost-Translational Protein ProcessingExperimental StudyModificationResponseBaseIn VivoUnited States National Institutes Of HealthResearch PersonnelTissuesPathway InteractionsRegulationSouth CarolinaGlucoseMethodologyO-Glcnac TransferaseInstitutionOverexpressionNatural Regeneration
Grant awards (30)
Thermo Scientific Orbitrap Astral Mass Spectrometer$1,658,828
S10 · FY2025 · OD · contact PI
Proteomics Core$271,800
P30 · FY2025 · GM · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$532,964
U01 · FY2024 · CA
Proteomics Core$271,800
P30 · FY2024 · GM · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$74,294
U01 · FY2024 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells$549,794
U01 · FY2023 · CA
Proteomics Core$271,800
P30 · FY2023 · GM · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$76,640
U01 · FY2023 · CA
Role of O-GlcNAcome on Breast Cancer Initiating Cells$549,794
U01 · FY2022 · CA
Proteomics Core$271,800
P30 · FY2022 · GM · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$69,871
U01 · FY2022 · CA
Quadrupole Orbitrap Hybrid Mass Spectrometer for Proteomics$772,652
S10 · FY2021 · OD · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$561,013
U01 · FY2021 · CA
Proteomics Core$270,975
P30 · FY2021 · GM · contact PI
Role of O-GlcNAcome on Breast Cancer Initiating Cells$575,137
U01 · FY2020 · CA
Proteomics Core$153,176
P20 · FY2020 · GM · contact PI
Proteomics Core$186,875
P20 · FY2019 · GM · contact PI
Orbitrap Fusion Lumos ETD Mass Spectrometer$990,760
S10 · FY2018 · OD · contact PI
Proteomics Core$186,875
P20 · FY2018 · GM · contact PI
Proteomics Core$186,875
P20 · FY2017 · GM · contact PI
Proteomics Core$186,875
P20 · FY2016 · GM · contact PI
Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation$365,063
R01 · FY2014 · DE · contact PI
Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation$350,460
R01 · FY2013 · DE · contact PI
Orbitrap Mass Spectrometer$600,000
S10 · FY2012 · OD · contact PI
Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation$365,063
R01 · FY2012 · DE · contact PI
Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation$357,688
R01 · FY2011 · DE · contact PI
Regulation of IGF-1 and Insulin Signaling by O-GlcNAc Glycosylation$368,750
R01 · FY2010 · DE · contact PI
COBRE P3: ROLE OF HEXOSAMINE BIOSYNTHETIC PATHWAY AND POSTRANSLATIONAL O-GLCNAC$153,839
P20 · FY2010 · RR · contact PI
COBRE P3: ROLE OF HEXOSAMINE BIOSYNTHETIC PATHWAY AND POSTRANSLATIONAL O-GLCNAC$189,308
P20 · FY2009 · RR · contact PI
COBRE P3: ROLE OF HEXOSAMINE BIOSYNTHETIC PATHWAY AND POSTRANSLATIONAL O-GLCNAC$127,286
P20 · FY2008 · RR · contact PI